Name Development Level Target Family
Tumor necrosis factor ligand superfamily member 11 Tclin Non-IDG
Name Description
denosumab A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS.
TCRDv4.6.0
DrugCentral Indication
DrugCentral
denosumab